However, only a few human clinical trials have been completed or are in the process, and they have shown very limited effects [198]; therefore, further studies are needed to deepen understanding of the role of ApoE4 in AD, in order to identify the best therapeutic approach for targeting ApoE. This evidence concerns the gene APOE and Alzheimer disease.